5AM Ventures

5AM Ventures is a venture capital firm based in San Francisco, California, that specializes in seed- and early-stage investments. Founded in 2002 by John Diekman and Andrew Schwab, the firm focuses on companies in advanced life science technologies, including biopharmaceuticals, medical technology, drug delivery technology, and research instruments. By targeting innovative firms in these sectors, 5AM Ventures aims to support the development of groundbreaking solutions in healthcare and related fields.

David Allison

Partner

Jamil Beg

Principal

John Diekman

Founder and Managing Partner

Max Farina

Principal

Michelle Ho

Associate

Pengpeng Li

Associate

Lucia C.F.A., CFA, Rebecca Lynn

Partner, CFO and COO

Palestrant Ph.D., Deborah

Partner

Kush Parmar Ph.D

Managing Partner

Scott M. Rocklage

Founding Partner

Schwab B.S., Andrew J.

Managing Partner

Arthur Tzianabos

Venture Partner

Rathnam Venkat

Analyst

Victor Jr., Joseph J.

Venture Partner

Past deals in TMT

TMRW Life Sciences

Series C in 2021
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.

TMRW Life Sciences

Series B in 2019
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.